Cargando…

The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19

INTRODUCTION: Coronavirus disease 2019 (Covid‐19) following venous thromboembolism (VTE) and blood hyperlactatemia are associated with higher mortality. However, reliable biomarkers for this association remain to be elucidated. This study investigated the associations of VTE risk and blood hyperlact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alshammary, Amal F., AlQarni, Hassan M., Farzan, Raed, Ali Khan, Imran, Vennu, Vishal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265175/ https://www.ncbi.nlm.nih.gov/pubmed/37144596 http://dx.doi.org/10.1111/crj.13628

Ejemplares similares

A conceptual model of factors associated with health-related quality of life in men and women with knee osteoarthritis in Riyadh, Saudi Arabia: A multicenter cross-sectional study
por: Vennu, Vishal, et al.
Publicado: (2023)

Even Mild Hyperlactatemia Is Associated with Increased Mortality in Critically Ill Patients
por: Rishu, Asgar H, et al.
Publicado: (2013)

Hyperlactatemia in critical illness and cardiac surgery
por: O'Connor, Enda D, et al.
Publicado: (2010)

Occurrence and adverse effect on outcome of hyperlactatemia in the critically ill
por: Khosravani, Houman, et al.
Publicado: (2009)

Hyperlactatemia and the Importance of Repeated Lactate Measurements in Critically Ill Patients
por: Godinjak, Amina, et al.
Publicado: (2017)

Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study
por: Nichol, Alistair D, et al.
Publicado: (2010)

Metabolic Syndrome and Coronary Artery Disease Risk: A Meta-Analysis of Observational Studies
por: Alshammary, Amal F., et al.
Publicado: (2021)

Prophylaxis and treatment of venous thromboembolism in the critically ill
por: Adriance, Sarah M, et al.
Publicado: (2013)

Venous Thromboembolism in Critical Illness and Trauma: Pediatric Perspectives
por: Chima, Ranjit S., et al.
Publicado: (2017)

The riddle of hyperlactatemia
por: Gutierrez, Guillermo, et al.
Publicado: (2009)

Venous thromboembolism in critically ill patients: incidence and risk factors
por: Al-Qahtani, S, et al.
Publicado: (2007)

Hemorrhage and venous thromboembolism in critically ill patients with COVID-19
por: Qiu, Chenyang, et al.
Publicado: (2021)

Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
por: Abdulla, Aliya, et al.
Publicado: (2023)

Hyperlactatemia caused by intra-venous administration of glycerol: A case study
por: Katayama, Shinshu, et al.
Publicado: (2012)

Venous Thromboembolism in Critically Ill Cirrhotic Patients: Practices of Prophylaxis and Incidence
por: Al-Dorzi, Hasan M., et al.
Publicado: (2013)

Venous thromboembolism in non-critically ill patients with COVID-19 infection
por: Trimaille, Antonin, et al.
Publicado: (2020)

Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients
por: Dujardin, Romein W.G., et al.
Publicado: (2020)

Venous thromboembolism in non-critically ill patients with COVID-19 infection
por: Trimaille, A., et al.
Publicado: (2021)

A study on the immunological vitality of an inflammatory biomarker explored with rs5743708 polymorphism in TLR2 gene among Saudi women confirmed with polycystic ovarian syndrome
por: Alshammary, Amal F., et al.
Publicado: (2023)

Sepsis-associated hyperlactatemia
por: Garcia-Alvarez, Mercedes, et al.
Publicado: (2014)

Deconstructing Hyperlactatemia in Sepsis Using Central Venous Oxygen Saturation and Base Deficit
por: Semler, Matthew W., et al.
Publicado: (2019)

The incidence of venous thromboembolism in critically ill patients with COVID-19 compared with critically ill non-COVID patients
por: Boyd, Sean, et al.
Publicado: (2021)

Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey
por: Cook, Deborah, et al.
Publicado: (2001)

Incidence, risk factors and outcome of venous thromboembolism in critically ill obstetric patients
por: Kaddour, C, et al.
Publicado: (2008)

Correction to: The incidence of venous thromboembolism in critically ill patients with COVID-19 compared with critically ill non-COVID patients
por: Boyd, Sean, et al.
Publicado: (2022)

Hyperlactatemia and low central venous saturation can predict prognosis after cardiac surgery
por: Hajjar, L, et al.
Publicado: (2008)

Relative Hyperlactatemia in the Emergency Department
por: Bou Chebl, Ralphe, et al.
Publicado: (2020)

Outcomes of hyperlactatemia on admission in critically ill patients with acute myocardial infarction: A retrospective study from MIMIC-IV
por: Lu, Ting, et al.
Publicado: (2022)

Dissecting the Molecular Role of ADIPOQ SNPs in Saudi Women Diagnosed with Gestational Diabetes Mellitus
por: Alshammary, Amal F., et al.
Publicado: (2023)

The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in medical and critically ill patients
por: Al-Hameed, Fahad M., et al.
Publicado: (2016)

Understanding Hyperlactatemia in Sepsis: Are We There Yet?
por: Nalos, Marek, et al.
Publicado: (2019)

An Economic Evaluation of Venous Thromboembolism Prophylaxis Strategies in Critically Ill Trauma Patients at Risk of Bleeding
por: Chiasson, T. Carter, et al.
Publicado: (2009)

Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship?
por: Stessel, Björn, et al.
Publicado: (2021)

Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis
por: Mohamed, Mouhand F. H., et al.
Publicado: (2021)

Prevalence of Venous Thromboembolism in Critically Ill Patients With Coronavirus Disease 2019: A Meta-Analysis
por: Wu, Changgang, et al.
Publicado: (2021)

Lymphocytes, Mean Platelet Volume, and Albumin in Critically Ill COVID-19 Patients with Venous Thromboembolism
por: Duan, Rundan, et al.
Publicado: (2023)

Venous Thromboembolism in Denmark: Seasonality in Occurrence and Mortality
por: Skajaa, Nils, et al.
Publicado: (2019)

Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19
por: Zermatten, Maxime G., et al.
Publicado: (2020)

Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients
por: Haksteen, Wolmet E., et al.
Publicado: (2021)

Arterial and venous thromboembolism in critically ill, COVID 19 positive patients admitted to Intensive Care Unit
por: Elboushi, Amro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3nl5uejncr5dia6lgagf0l4hq6